← Back to Search

Telehealth Consultations for Brain Cancer

N/A

Recruiting

Led By Sara Hardy, MD

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time of early start visit [on average between 3-4 months after diagnosis]

Awards & highlights

Study Summary

This trial will create an Early START visit for patients with high grade gliomas to discuss end of life wishes soon after their initial oncology visit. A checklist and pre-visit guide will be used to help guide the visit for both the provider and patient.

Who is the study for?

This trial is for English-speaking patients who have been newly diagnosed with high-grade gliomas (WHO grade III or IV) within the past four months. It's not suitable for those with severe cognitive dysfunction or aphasia that would prevent them from discussing end-of-life care plans.Check my eligibility

What is being tested?

The study tests an 'Early START' program where patients use telehealth services like phone or Zoom to discuss their end-of-life wishes using a checklist and guide, soon after diagnosis. Providers are trained for these visits, which include family members, and technology is provided if needed.See study design

What are the potential side effects?

Since this intervention involves discussions rather than medical treatments, there are no direct physical side effects. However, participants may experience emotional distress when discussing sensitive topics about end-of-life care.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time of early start visit [on average between 3-4 months after diagnosis]

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time of early start visit [on average between 3-4 months after diagnosis]

This trial's timeline: 3 weeks for screening, Varies for treatment, and time of early start visit [on average between 3-4 months after diagnosis] for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Advanced Directive Completion Rate

Secondary outcome measures

Advanced Care Directive Completion by patient vs proxy

Checklist use

Pharmacotherapy

+5 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Early STructured Advanced care Referrals by TelehealthExperimental Treatment1 Intervention

Early START visit using checklist over telephone or zoom: A telehealth visit conducted within 4 months of patient diagnosis, with the goal of encouraging patients to discuss and document their end-of-life wishes prior to the onset of cognitive impediments common among patients with late-stage high grade glioma.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor

842 Previous Clinical Trials

533,988 Total Patients Enrolled

Sara Hardy, MDPrincipal InvestigatorUniversity of Rochester

Media Library

Early START visit using checklist over telephone or zoom Clinical Trial Eligibility Overview. Trial Name: NCT04543201 — N/A

Brain Tumor Research Study Groups: Early STructured Advanced care Referrals by Telehealth

Brain Tumor Clinical Trial 2023: Early START visit using checklist over telephone or zoom Highlights & Side Effects. Trial Name: NCT04543201 — N/A

Early START visit using checklist over telephone or zoom 2023 Treatment Timeline for Medical Study. Trial Name: NCT04543201 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are actively engaged in this research endeavor?

"Affirmative, clinicaltrials.gov displays that this research trial is actively looking for volunteers. It was initially announced on August 26th 2021 and adjusted most recently on November 9th 2021. This study aims to include 50 participants in one location."

Answered by AI

Is this investigation accepting new participants at this time?

"Per the data on clinicaltrials.gov, this research is still enrolling participants as of November 9th 2021. The trial was first launched on August 26th 2021 and has been regularly updated since then."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma

Sara J Hardy 2021. "Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04543201.

All > Glioma